Literature DB >> 11522668

A low-affinity Ca2+-dependent association of calmodulin with the Rab3A effector domain inversely correlates with insulin exocytosis.

H Kajio1, S Olszewski, P J Rosner, M J Donelan, K F Geoghegan, C J Rhodes.   

Abstract

The stimulus-response coupling pathway for glucose-regulated insulin secretion has implicated a rise in cytosolic [Ca2+]i as a key factor to induce insulin exocytosis. However, it is unclear how elevated [Ca2+]i communicates with the pancreatic beta-cell's exocytotic apparatus. As Rab3A is a model protein involved in regulated exocytosis, we have focused on its role in regulating insulin exocytosis. By using a photoactivatable cross-linking synthetic peptide that mimics the effector domain of Rab3A and microsequence analysis, we found calmodulin to be a major Rab3A target effector protein in pancreatic beta-cells. Coimmunoprecipitation analysis from pancreatic islets confirmed a Rab3A-calmodulin interaction in vivo, and that it inversely correlated with insulin exocytosis. Calmodulin affected neither GTPase nor guanine nucleotide exchange activity of Rab3A. The calmodulin-Rab3A interaction was pH- and Ca2+-dependent, and it was preferential for GTP-bound Rab3A. However, Rab3A affinity for calmodulin was relatively low (Kd = 18-22 micromol/l at 10(-5) mol/l [Ca2+]) and competed by other calmodulin-binding proteins that had higher affinity (e.g., Ca2+/calmodulin-dependent protein kinase-2 [CaMK-2] [Kd = 300-400 nmol/l at 10(-5) mol/l [Ca2+]]). Moreover, the Ca2+ dependence of the calmodulin-Rab3A interaction (K0.5 = 15-18 micromol/l [Ca2+], maximal at 100 micromol/l [Ca2+]) was significantly lower compared with that of the calmodulin-CaMK-2 association (K0.5 = 40 micromol/l [Ca2+], maximal at 1 mmol/l [Ca2+]). The data suggested that a transient Rab3A-calmodulin interaction might represent a means of directing calmodulin to the cytoplasmic face of a beta-granule, where it can be subsequently transferred for activation of other beta-granule-associated calmodulin-binding proteins as local [Ca2+]i rises to promote insulin exocytosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522668     DOI: 10.2337/diabetes.50.9.2029

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  ATP-independent luminal oscillations and release of Ca2+ and H+ from mast cell secretory granules: implications for signal transduction.

Authors:  Ivan Quesada; Wei-Chun Chin; Pedro Verdugo
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

Review 2.  Small G proteins in islet beta-cell function.

Authors:  Anjaneyulu Kowluru
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

3.  GTP binds to Rab3A in a complex with Ca2+/calmodulin.

Authors:  Jae-Bong Park; Jun-Sub Kim; Jae-Yong Lee; Jaebong Kim; Ji-Yeon Seo; Ah-Ram Kim
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

4.  The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach.

Authors:  Hongfang Lu; Ying Yang; Emma M Allister; Nadeeja Wijesekara; Michael B Wheeler
Journal:  Mol Cell Proteomics       Date:  2008-04-30       Impact factor: 5.911

5.  Targeted inactivation of kinesin-1 in pancreatic β-cells in vivo leads to insulin secretory deficiency.

Authors:  Ju Cui; Zai Wang; Qianni Cheng; Raozhou Lin; Xin-Mei Zhang; Po Sing Leung; Neal G Copeland; Nancy A Jenkins; Kwok-Ming Yao; Jian-Dong Huang
Journal:  Diabetes       Date:  2010-09-24       Impact factor: 9.461

Review 6.  Pleiotropic Roles of Calmodulin in the Regulation of KRas and Rac1 GTPases: Functional Diversity in Health and Disease.

Authors:  Francesc Tebar; Albert Chavero; Neus Agell; Albert Lu; Carles Rentero; Carlos Enrich; Thomas Grewal
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

7.  Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation.

Authors:  Nils Paulmann; Maik Grohmann; Jörg-Peter Voigt; Bettina Bert; Jakob Vowinckel; Michael Bader; Masa Skelin; Marko Jevsek; Heidrun Fink; Marjan Rupnik; Diego J Walther
Journal:  PLoS Biol       Date:  2009-10-27       Impact factor: 8.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.